Gene Therapy Clinical Trial Services Market Growth Driven by Personalized Medicine Demand
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Gene Therapy Clinical Trial Services Market Progress Between 2026 And 2030?
The gene therapy clinical trial services market has seen rapid expansion in recent years. It is anticipated to expand from $1.82 billion in 2025 to $2.18 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 19.4%. The historical growth of this market can be attributed to heightened investment in gene therapy research and development, the expansion of early-stage gene therapy pipelines, growing collaborations between biotechnology firms and CROs, the increasing intricacy of gene therapy trial protocols, and enhanced regulatory oversight of advanced therapies.
The gene therapy clinical trial services market size is projected for swift expansion over the next few years. It is predicted to reach $4.39 billion by 2030, achieving a compound annual growth rate (CAGR) of 19.1%. This growth during the forecast period is primarily fueled by an increasing number of late-stage gene therapy trials, a rising demand for global trial execution capabilities, the expansion of rare disease gene therapy programs, the growing use of digital trial management platforms, and an increasing focus on accelerated regulatory approvals. Furthermore, significant trends in the upcoming period include an increasing demand for specialized gene therapy trial management, the rising adoption of decentralized and hybrid trial models, a growing focus on advanced cold chain and logistics support, the expansion of patient-centric trial design approaches, and an enhanced emphasis on regulatory and data integrity services.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Primary Drivers Are Impacting The Gene Therapy Clinical Trial Services Market Growth?
The rising need for personalized medicine is anticipated to drive the future expansion of the gene therapy clinical trial services market. Personalized medicine represents a method where medical treatments are customized based on distinct individual traits, including genetic makeup, biomarkers, and lifestyle elements. This surge in personalized medicine demand stems from progress in genomics and biotechnology, facilitating more exact targeting of therapeutic interventions. Gene therapy clinical trial services facilitate personalized medicine through the examination of patient-specific genetic profiles and the subsequent tailoring of treatments. They employ biomarker analysis and companion diagnostics to fine-tune therapy for every individual, thereby improving both safety and effectiveness. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care entity, reported that the FDA cleared 16 novel personalized treatments for patients with rare diseases in 2023, an increase from six in 2022. Consequently, the escalating need for personalized medicine is a key factor propelling the growth of the gene therapy clinical trial services market.
How Are Segments Identified Within The Gene Therapy Clinical Trial Services Market Segment Framework?
The gene therapy clinical trial services market covered in this report is segmented –
1) By Type: Clinical Trial Design And Planning, Supply And Logistics Services, Regulatory Services, Data Management And Biostatistics, Site Management And Monitoring, Other Types
2) By Application: Oncology, Hematology, Endocrine or Metabolic Disorders, Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Applications
3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Government Research Institutes, Contract Research Organizations (CROs)
Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development, Feasibility Studies, Patient Recruitment Strategy Design
2) By Supply And Logistics Services: Cold Chain Management, Investigational Product Packaging And Labeling, Controlled-Temperature Storage
3) By Regulatory Services: Regulatory Consulting And Strategy, Ethics Committee Submissions, Regulatory Compliance Monitoring
4) By Data Management And Biostatistics: Clinical Data Capture And Database Design, Data Validation And Quality Control, Statistical Analysis And Modeling
5) By Site Management And Monitoring: Site Selection And Qualification, Investigator Training And Support, On-Site Monitoring Visits
6) By Other Types: Pharmacovigilance And Safety Reporting, Quality Assurance And Auditing, Patient Engagement And Retention
Which Trends Are Shaping Growth In The Gene Therapy Clinical Trial Services Market?
Companies operating in the gene therapy clinical trial services market are prioritizing the creation of novel solutions like the long-term follow-up (LTFU) model for cell and gene therapy (CGT) trials. This strategy aims to speed up the overall trial process while adhering to regulatory requirements and safety standards. A Long-Term Follow-Up (LTFU) model for cell and gene therapy (CGT) trials serves as a structured system for monitoring patients over an extended period, often up to 15 years after they receive a CGT treatment. For example, in May 2025, Medable Inc., a US-based SaaS company, unveiled a digital-first Long-Term Follow-Up (LTFU) model specifically designed for cell and gene therapy (CGT) trials. This model supports cell and gene therapy trials by lessening patient and site burdens while ensuring scientific rigor over the FDA-required 15-year monitoring duration. It boosts patient access, retention, and data continuity through remote and hybrid follow-up methods, thereby improving the monitoring of long-term safety and efficacy.
Who Are The Companies Competing Within The Gene Therapy Clinical Trial Services Market?
Major companies operating in the gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, Labcorp, Pharmaceutical Product Development LLC, ICON plc, Syneos Health Inc., WuXi AppTec, Franklin Biolabs, Catalent Inc., Charles River Laboratories International Inc., Parexel International Corporation, Medpace Holdings Inc., Precision Medicine Group LLC, Worldwide Clinical Trials, IQVIA Holdings Inc., TFS HealthScience, Veristat LLC, Novotech Health Holdings Pte Limited, Covance Inc., PPD Clinical Research Services, PRA Health Sciences Inc.
Get The Full Gene Therapy Clinical Trial Services Market Report:
Which Region Leads The Gene Therapy Clinical Trial Services Market In Overall Market Size?
North America was the largest region in the gene therapy clinical trial services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy clinical trial services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Gene Therapy Clinical Trial Services Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Gene Therapy Clinical Trial Services Market 2026, By The Business Research Company
Ranibizumab Market Report 2026
https://www.thebusinessresearchcompany.com/report/ranibizumab-global-market-report
Nitrobenzene Market Report 2026
https://www.thebusinessresearchcompany.com/report/nitrobenzene-global-market-report
Triazole Fungicides Market Report 2026
https://www.thebusinessresearchcompany.com/report/triazole-fungicides-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
